Sentri7 AI+ enhancements to its stewardship solutions finds patients at risk for C. difficile infection or opioid events earlier and provides evidence-based guidance so teams can proactively address those risks.

LEARN MORE ABOUT:
Antimicrobial Stewardship - AI improves C. difficile infection risk detection with a CDI Risk Score
Empower pharmacy teams to move from reactive care to proactive care to prevent healthcare-associated C. difficile infections and improve stewardship performance. Read about Sentri7 Antimicrobial Stewardship>

  • A multidisciplinary team-validated AI model - Physicians, epidemiologists, antimicrobial stewardship experts and data scientists across Wolters Kluwer analyzed millions of deidentified records to cultivate a validated AI model for assessing C. difficile patient risk.

  • Sentri7's AI-powered surveillance and predictive CDI algorithm continuously monitor the inpatient hospital population in real-time to identify at-risk patients sooner.

  • Evidence-based rules track patients at elevated risk and suggested actions help clinical teams put evidence into practice sooner to proactively prevent healthcare-associated C. difficile infections.

  • Patients’ risk scores automatically update as the patient condition and risk factors change, allowing clinicians to address modifiable risk factors at appropriate stages.

Opioid Stewardship - AI delivers a real-time Morphine Milligram Equivalent (MME) calculation 
Support compliance with the Joint Commission's standards, improve inpatient opioid use and patient safety. Read more about Sentri7 Opioid Stewardship>

  • Real-time and precise MME calculations are powered by AI - Sentri7 leverages machine learning to analyze complex dosing data sets to automatically calculate patient-specific, real-time Morphine Milligram Equivalent (MME).

  • Sentri7 uses AI to continuously analyze the MME calculation over 24-hours and automatically updates it based on opioid dose administrations provided to the patient.

  • Evidence-based rules, combined with AI-powered tools and insights, identify and monitor patients at risk for opioid-related adverse events and opportunities to discontinue use or change agents to improve patient care and safety.

Generic Page
Salud
Opioid Stewardship
Empowering hospital pharmacy teams to improve opioid use and patient safety
Más información
Infografía
Saludagosto 18, 2020
Pharmacists impact C. difficile infection rates using AI to improve care

AI technology helps pharmacists identify at-risk patients sooner to improve prevention and treatment to optimize patient care and hospitals' performance.
Más información

Learn More About Sentri7 AI+!

To request a demo and price quote for Sentri7 AI+, please fill out the form.

Learn more via our expert insights - Opioid Stewardship

The relentless focus on COVID-19 has relegated the opioid epidemic to a much lower priority public health problem than the numbers and societal effects merit. While the opioid epidemic is a broad societal problem, health systems must be at the center of the response. That response should include implementation and expansion of opioid stewardship programs (OSPs), often with pharmacists leading the charge because of their consistent presence at the hub of hospital and health system opioid use. In this guide Dr. Steven Riddle reviews: How we’ve got to where we are with the opioid epidemic and the impacts that COVID-19 has had on it Key guiding principles for opioid stewardship programs The value of a data-driven opioid stewardship program and key metrics to measure to reduce opioid use and manage risk
The Need for Opioid Stewardship Intensifies: COVID-19 Exposes Lack of Progress

By many accounts, 2020 was the worst year yet of the opioid epidemic. The need for opioid stewardship is more important than ever.

Access Guide
Opioid stewardship
Wolters Kluwer applies AI technology to improve hospital pharmacy opioid use and patient safety
Sentri7 delivers patient-specific, real-time Morphine Milligram Equivalent calculation to support opioid stewardship and proactive pain management at hospitals. 
Learn More
Facts and statistics about opioid addiction
Initiating Opioid Stewardship for Inpatients: Using Tools and Technology to Jumpstart Your Program

Discover the impact of initiating opioid stewardship for inpatients and how tools and technology can jumpstart your program.

Watch Video
Sentri7-opioid-stewardship-analytics-on-laptop
Building a successful Opioid Stewardship program: What you need to know

This video explores hospitals' current focus with opioid stewardship programs, challenges hospitals face when trying to launch or expand their programs and the tools and information needed to make these programs successful.

Watch Video

Learn More Via our Expert Insights – C. difficile infection Risk Detection  

Wolters Kluwer adds AI to clinical surveillance for faster C difficile infection prediction
Wolters Kluwer adds AI to clinical surveillance for faster C. difficile infection prediction
Sentri7’s predictive C. diff infection risk score helps hospitals identify at-risk patients sooner and proactively address modifiable risk factors to prevent infection and improve outcomes
Learn More
four-clinicians-collaborating-in-hospital-hallway
What you Need to Know about C. difficile Risk Factors
C. difficile infection has become the most common cause of healthcare-associated infections (HAI) in U.S. hospitals. Discover the impact of real-time monitoring.
Learn More
Touchscreen showing the different features of AI
AI is a game changer for preventing C. difficile infections
Hospitals around the world continue to struggle with preventing and managing Clostridioides difficile (C. diff) infections. They are seeking better ways to predict which patients are at risk for C. diff infections (CDIs) sooner, and to improve prevention and treatment.
Learn More
Pharmacy team talking
Transforming antimicrobial stewardship using artificial intelligence
Artificial Intelligence (AI) is widely used in our everyday lives. This on-demand webinar will showcase how AI can be used to improve antimicrobial stewardship (AMS)—specifically improving medication prescribing, patient monitoring and pharmacy workflow.
Access Webinar
Wolters Kluwer Clinical Surveillance receives Frost & Sullivan New Product Innovation Award
Independent analysis by Frost & Sullivan found that “Wolters Kluwer is positioning its clinical surveillance program as an outstanding resource that can spot at-risk patients more quickly than other surveillance products while also delivering exceptional alert quality.”
Learn More
Back To Top